KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 17 filers reported holding KAZIA THERAPEUTICS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | -13.8% | 25 | 0.0% | 0.00% | – |
| Q2 2023 | $29 | +11.5% | 25 | 0.0% | 0.00% | – |
| Q1 2023 | $26 | -43.5% | 25 | -66.7% | 0.00% | – |
| Q4 2022 | $46 | – | 75 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 75 | -25.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -100.0% | 100 | -50.0% | 0.00% | – |
| Q1 2021 | $2,480,000 | +247900.0% | 200 | +100.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 100 | -69.2% | 0.00% | – |
| Q2 2020 | $1,000 | – | 325 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 325 | -43.5% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 575 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 575 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 575 | +4.5% | 0.00% | – |
| Q3 2018 | $2,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 99,180 | $857,000 | 0.09% |
| HighPoint Advisor Group LLC | 32,435 | $368,000 | 0.04% |
| Transform Wealth, LLC | 106,245 | $95,000 | 0.02% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 19,600 | $170,000 | 0.00% |
| Renaissance Technologies | 79,625 | $688,000 | 0.00% |
| TRUIST FINANCIAL CORP | 35,260 | $304,000 | 0.00% |
| UBS Group AG | 2,851 | $25,000 | 0.00% |
| BREWIN DOLPHIN LTD | 32 | $276 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,800 | $24,000 | 0.00% |